Prognostic prediction of glioblastoma by quantitative assessment of the methylation status of the entire MGMT promoter region

BACKGROUND: O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is reported to be a prognostic and predictive factor of alkylating chemotherapy for glioblastoma patients. Methylation specific PCR (MSP) has been most commonly used when the methylation status of MGMT is assessed. Howeve...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kanemoto, Manabu, Shirahata, Mitsuaki, Nakauma, Akiyo, Nakanishi, Katsumi, Taniguchi, Kazuya, Kukita, Yoji, Arakawa, Yoshiki, Miyamoto, Susumu, Kato, Kikuya
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4161852/
https://ncbi.nlm.nih.gov/pubmed/25175833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-641
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires